Current Cancer Drug Targets
Title:Editorial (Thematic Issue: Targeted Anti-Cancer Drug Delivery)
Volume: 16 Issue: 6
Author(s): Feng Liang, Bo Chen and Chao Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Liang Feng, Chen Bo and Zhang Chao, Editorial (Thematic Issue: Targeted Anti-Cancer Drug Delivery), Current Cancer Drug Targets 2016; 16 (6) . https://dx.doi.org/10.2174/156800961606160616181308
DOI https://dx.doi.org/10.2174/156800961606160616181308 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
33
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phospho-eIF4E: A New Target for Acute Myeloid Leukemia
Current Protein & Peptide Science Efficient Gene Transfer to Rat Fetal Osteoblastic Cells by Synthetic Peptide Vector System
Protein & Peptide Letters Gold Nanoparticles as Carrier(s) for Drug Targeting and Imaging
Pharmaceutical Nanotechnology Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Rational Design of 5-Aminolevulinic Acid Derivatives Aimed at Improving Photodynamic Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis
Current Molecular Medicine Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
Current Drug Targets Curbing the Deregulation of Glycosylation in Tongue Carcinoma Cells with Natural Compounds
Anti-Cancer Agents in Medicinal Chemistry Topical Targeting Therapies for Sexually Transmitted Diseases
Current Nanoscience Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine
Letters in Drug Design & Discovery Roles of NHERF1/EBP50 in Cancer
Current Molecular Medicine Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery Current Targets for Anticancer Drug Discovery
Current Drug Targets Natural Proteinaceous Inhibitors of Serine Proteases
Current Pharmaceutical Design Recent Advances in Curcumin Nanocarriers for the Treatment of Different Types of Cancer with Special Emphasis on In Vitro Cytotoxicity and Cellular Uptake Studies
Nanoscience & Nanotechnology-Asia The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology Vitamins for Cancer Prevention and Treatment: An Insight
Current Molecular Medicine Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
Current Drug Delivery